Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Berger

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Psychopharmacology|August 1, 1996
Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatmentB K Tolliver, L B Ho, M S Reid, et al.
Lupus|March 3, 2011
Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritisG M N Daleboudt, E Broadbent, S P Berger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulantsB K Tolliver, L B Ho, M S Reid, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamineB K Tolliver, L B Ho, L M Fox, et al.
Journal of Addictive Diseases|October 30, 2001
The D3 dopamine receptor and substance dependenceN M Richtand, R J Goldsmith, J E Nolan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 1999
A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjectsM S Reid, J D Mickalian, K L Delucchi, et al.
Neuroscience and Biobehavioral Reviews|September 22, 2001
D3 dopamine receptor, behavioral sensitization, and psychosisN M Richtand, S C Woods, S P Berger, et al.
Molecular Pharmacology|October 1, 1994
Radiation inactivation studies of the dopamine reuptake transporter proteinS P Berger, K Farrell, D Conant, et al.
Psychopharmacology|August 1, 1995
The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivityC A Crawford, S A McDougall, C A Bolanos, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitizationM S Reid, K Hsu, B K Tolliver, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Psychopharmacology|August 1, 1996
Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatmentB K Tolliver, L B Ho, M S Reid, et al.
Lupus|March 3, 2011
Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritisG M N Daleboudt, E Broadbent, S P Berger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulantsB K Tolliver, L B Ho, M S Reid, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamineB K Tolliver, L B Ho, L M Fox, et al.
Journal of Addictive Diseases|October 30, 2001
The D3 dopamine receptor and substance dependenceN M Richtand, R J Goldsmith, J E Nolan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 1999
A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjectsM S Reid, J D Mickalian, K L Delucchi, et al.
Neuroscience and Biobehavioral Reviews|September 22, 2001
D3 dopamine receptor, behavioral sensitization, and psychosisN M Richtand, S C Woods, S P Berger, et al.
Molecular Pharmacology|October 1, 1994
Radiation inactivation studies of the dopamine reuptake transporter proteinS P Berger, K Farrell, D Conant, et al.
Psychopharmacology|August 1, 1995
The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivityC A Crawford, S A McDougall, C A Bolanos, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitizationM S Reid, K Hsu, B K Tolliver, et al.
Pageof 5